FDA.reportPublic FDA data

fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters

RxCUI
1547658
RxNorm name
fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters
Display name
fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters
Full name
fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 30 Blisters
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Fluticasone Furoate ElliptaFLUTICASONE FUROATEPrasco Laboratoriesd3e797fc-2636-49a0-b89e-5246b18ee4402025-03-06Warnings, Adverse reactionsExact identifier
rxcui: 1547658
Arnuity ElliptaFLUTICASONE FUROATEGlaxoSmithKline LLC50f193ee-1691-486d-9370-a664df63695c2023-10-18Warnings, Adverse reactionsExact identifier
rxcui: 1547658

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
50f193ee-1691-486d-9370-a664df63695cfluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 30 BlistersPSN17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
50f193ee-1691-486d-9370-a664df63695c30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT Dry Powder InhalerSCD17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
50f193ee-1691-486d-9370-a664df63695cfluticasone furoate 100 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUATSY17These highlights do not include all the information needed to use ARNUITY ELLIPTA safely and effectively. See full prescribing information for ARNUITY ELLIPTA. ARNUITY ELLIPTA (fluticasone furoate inhalation powder), for oral inhalation use Initial U.S. Approval: 201420231018
d3e797fc-2636-49a0-b89e-5246b18ee440fluticasone furoate 100 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUATSY2These highlights do not include all the information needed to use Fluticasone Furoate ELLIPTA safely and effectively. See full prescribing information for Fluticasone Furoate ELLIPTA. Fluticasone Furoate ELLIPTA inhalation powder, for oral inhalation use Initial U.S. Approval: 201420250306
d3e797fc-2636-49a0-b89e-5246b18ee440fluticasone furoate 100 MCG/INHAL Dry Powder Inhaler, 30 BlistersPSN2These highlights do not include all the information needed to use Fluticasone Furoate ELLIPTA safely and effectively. See full prescribing information for Fluticasone Furoate ELLIPTA. Fluticasone Furoate ELLIPTA inhalation powder, for oral inhalation use Initial U.S. Approval: 201420250306
d3e797fc-2636-49a0-b89e-5246b18ee44030 ACTUAT fluticasone furoate 0.1 MG/ACTUAT Dry Powder InhalerSCD2These highlights do not include all the information needed to use Fluticasone Furoate ELLIPTA safely and effectively. See full prescribing information for Fluticasone Furoate ELLIPTA. Fluticasone Furoate ELLIPTA inhalation powder, for oral inhalation use Initial U.S. Approval: 201420250306